Clinical Ink - "Next Generation" EDC Made Even Easier for Sites and Sponsors with Capture 6

HORSHAM, Pa., Sept. 26, 2018 /PRNewswire-PRWeb/ -- http://Clinicalink.com, the provider of Next-Generation EDC, eCOA and ePRO solutions for clinical development, announced today the release of Capture 6, the first true paperless EDC system. This latest release simplifies the most cumbersome tasks so that sites can focus on executing the protocol and sponsors can have confidence the right data is collected in real-time during the patient visit.

Advertisement

Capture 6 is Clinical Ink's "Next-Generation" EDC and eCOA solution and was purpose-built to capture data during the patient visit allowing true real-time access to both documents and data. In addition to comprehensively updating the entire user experience, innovative new functionality makes data capture, query resolution, and remote monitoring even better for sites and sponsors. Key highlights of Capture 6 include:

• Query resolution directly on the tablet
• Comprehensive User Interface redesign; Key metrics visibility
• Sophisticated cross-form validations, data pre-population, and monitoring review triggers
• Enhanced Data Validation and Change Management workflow
• Simplified Patient search/filtering/selection process
• Optimized Supply Accountability workflows and streamlined IWRS integration setup
• Simplified capture of Adverse Events, Medical History, and Concomitant Medications
• Robust Subject Mode authentication and sequential form workflows

"The current EDC market is long overdue for innovation that makes clinical trials easier for sites to conduct and gives sponsors confidence that the data are collected accurately, efficiently, and consistent with the protocol," said Jonathan Andrus, COO Clinical Ink. "We've taken the past 6 years of eSource experience in hundreds of clinical trials and updated our application to simplify even the most complicated tasks so that sites can readily capture data in real-time during the patient visit. Sponsors using Capture 6 will find that sites can readily adopt eSource as part of their routine daily work – ensuring cleaner data, faster."

About Clinical Ink Clinical Ink is a global clinical trial technology company that is transforming the clinical trial experience. Founded in 2007, the Company's proven and future-built eSource platform, which includes solutions for Next Generation EDC, eCOA, ePRO and more, accelerates time to value while delivering scientific results that matter. With offices in Winston-Salem, NC, and Philadelphia, PA, Clinical Ink is advancing the business model responsible for bringing new treatments to market. Visit http://www.clinicalink.com

 

SOURCE Clinical Ink